WAGNER, Thomas,CARLSSON, Malin,STAUM KALTOFT, Margit
申请号：
AU2020203917
公开号：
AU2020203917A1
申请日:
2020.06.12
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020203917A120200702.pdf#####ABSTRACT The invention relates to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of inflammatory disorders such as rheumatoid arthritis according to specific dosing regimen. The invention relates also to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of pain, e.g. pain experienced in inflammatory disorders such as rheumatoid arthritis, according to specific dosage regimen.
